- Home
- CSIQ vs IMTX Comparison
CSIQ vs IMTX Comparison
Compare CSIQ & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSIQ | IMTX |
|---|---|---|
| Founded | 2001 | N/A |
| Country | Canada | Germany |
| Employees | N/A | 423 |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CSIQ | IMTX |
|---|---|---|
| Price | $19.89 | $9.56 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $18.58 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 3.3M | 350.6K |
| Earning Date | 03-24-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,899,139,000.00 | $99,445,031.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.05 | $19.39 |
| P/E Ratio | $82.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.57 | $3.30 |
| 52 Week High | $34.59 | $12.41 |
Technical Indicators
Market Signals| Indicator | CSIQ | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.77 | 42.67 |
| Support Level | $18.75 | $8.55 |
| Resistance Level | $21.58 | $10.55 |
| Average True Range (ATR) | 1.41 | 0.56 |
| MACD | -0.09 | -0.08 |
| Stochastic Oscillator | 19.68 | 26.00 |
Price Performance
Historical ComparisonAbout CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.